1. Home
  2. RNA vs KAI Comparison

RNA vs KAI Comparison

Compare RNA & KAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNA
  • KAI
  • Stock Information
  • Founded
  • RNA 2012
  • KAI 1991
  • Country
  • RNA United States
  • KAI United States
  • Employees
  • RNA N/A
  • KAI N/A
  • Industry
  • RNA Biotechnology: Pharmaceutical Preparations
  • KAI Industrial Machinery/Components
  • Sector
  • RNA Health Care
  • KAI Industrials
  • Exchange
  • RNA Nasdaq
  • KAI Nasdaq
  • Market Cap
  • RNA 4.4B
  • KAI 4.1B
  • IPO Year
  • RNA 2020
  • KAI N/A
  • Fundamental
  • Price
  • RNA $28.92
  • KAI $367.03
  • Analyst Decision
  • RNA Strong Buy
  • KAI Buy
  • Analyst Count
  • RNA 10
  • KAI 2
  • Target Price
  • RNA $65.80
  • KAI $355.00
  • AVG Volume (30 Days)
  • RNA 1.4M
  • KAI 123.1K
  • Earning Date
  • RNA 02-26-2025
  • KAI 02-12-2025
  • Dividend Yield
  • RNA N/A
  • KAI 0.35%
  • EPS Growth
  • RNA N/A
  • KAI N/A
  • EPS
  • RNA N/A
  • KAI 9.77
  • Revenue
  • RNA $10,117,000.00
  • KAI $1,034,032,999.00
  • Revenue This Year
  • RNA N/A
  • KAI $11.00
  • Revenue Next Year
  • RNA N/A
  • KAI $3.57
  • P/E Ratio
  • RNA N/A
  • KAI $37.57
  • Revenue Growth
  • RNA N/A
  • KAI 8.72
  • 52 Week Low
  • RNA $9.93
  • KAI $249.51
  • 52 Week High
  • RNA $56.00
  • KAI $429.95
  • Technical
  • Relative Strength Index (RSI)
  • RNA 37.85
  • KAI 55.19
  • Support Level
  • RNA $26.74
  • KAI $319.35
  • Resistance Level
  • RNA $31.06
  • KAI $362.70
  • Average True Range (ATR)
  • RNA 1.77
  • KAI 9.26
  • MACD
  • RNA 0.24
  • KAI 3.32
  • Stochastic Oscillator
  • RNA 37.85
  • KAI 85.60

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.

About KAI Kadant Inc

Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence with sizable revenue from the U.S., Europe, Asia, and Canada.

Share on Social Networks: